Trial intelligence / Profile preview

Pentoxifylline for Imbalance Secondary to Insufficient Microvascular Perfusion

NCT02592863Terminated

Sponsor
University of Missouri
Start
Jan 2015
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in vestibular dysfunction, dizziness and vertigo comparing Pentoxifylline with Placebo (2 arms). Primary endpoints: Dizziness Handicap Inventory at 12 weeks, European Evaluation of Vertigo Scale at 12 weeks and 1 more. Started Jan 2015; status: terminated.

02

Drugs

pentoxifylline
03

Conditions

vestibular dysfunctiondizzinessvertigo

Beyond the preview

Go deeper on NCT02592863.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02592863.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call